This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision Next revisionBoth sides next revision |
| mrepo:topics:medications [20/04/2018 @ 11:32] – [Medication] adammoore | mrepo:topics:medications [20/04/2018 @ 11:41] – [Medication] adammoore |
|---|
| The [[questionnaires:2009|2006-10]] data collection was slightly different, in that study members were asked two sets of medication questions. The postal questionnaire (PQ) contained the usual phrasing about //regular taking// of medications, whereas the home visit (HV) asked for details of medications taken //in the past 24 hours.// When the overall derived measures were created, the __primary__ method used was to combine both postal and home visit data, with priority given to the home visit, unless missing. The nurse undertaking the visit was presented with the medications by the study member, so the accuracy of reporting could be more assured. However, alternative derivations of PQ or HV alone, or with HV priority, are also available. | The [[questionnaires:2009|2006-10]] data collection was slightly different, in that study members were asked two sets of medication questions. The postal questionnaire (PQ) contained the usual phrasing about //regular taking// of medications, whereas the home visit (HV) asked for details of medications taken //in the past 24 hours.// When the overall derived measures were created, the __primary__ method used was to combine both postal and home visit data, with priority given to the home visit, unless missing. The nurse undertaking the visit was presented with the medications by the study member, so the accuracy of reporting could be more assured. However, alternative derivations of PQ or HV alone, or with HV priority, are also available. |
| \\ \\ | \\ \\ |
| The entire NSHD medication data were thoroughly reviewed in 2017 and an ultimate set of derived measures were created, listing drug use at the various timepoints for a number of 'classes' of medical condition. Please view the {{mrepo:medication_MR_derived.pdf|documentation}} for the classes of condition covered and the medications relating to these classes. \\ ** However**, due to the sensitive and possibly disclosive nautre of medication data, particularly for rarer diseases, //only summary variables are available//. | The entire NSHD medication data were thoroughly reviewed in 2017 and an ultimate set of derived measures were created, listing drug use at the various timepoints for a number of 'classes' of medical condition. Please view the {{mrepo:medication_MR_derived.pdf|documentation}} for the classes of condition covered and the medications relating to these classes. \\ ** However**, due to the sensitive and possibly disclosive nature of medication data, particularly for rarer diseases, //only summary variables are available//. Particularly rare classes of drug may have been removed completely. |
| | |
| |
